Side-by-side comparison of AI visibility scores, market position, and capabilities
Impulse Dynamics makes the Optimizer Smart Mini, the first FDA-approved device for Cardiac Contractility Modulation (CCM) therapy in NYHA Class III heart failure patients; conducting AIM HIGHer RCT targeting expanded indication (LVEF 40–60%).
Impulse Dynamics is a medical device company founded in 1996 that developed and commercialized Cardiac Contractility Modulation (CCM®) therapy — a proprietary approach to treating chronic heart failure that is distinct from pacemakers, ICDs, or cardiac resynchronization therapy (CRT). CCM therapy delivers precisely timed, high-energy electrical signals to the right ventricle during the absolute refractory period, when the heart cannot be paced. These signals do not alter heart rhythm but instead improve the contractile force of cardiac muscle — addressing the fundamental mechanical impairment of heart failure.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Impulse Dynamics vs
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.